Lusomedicamenta

Lusomedicamenta is a prominent Portuguese contract development and manufacturing organization (CDMO) that provides comprehensive services to the global pharmaceutical industry. The company specializes in the development and large-scale production of a diverse range of dosage forms, including solids, liquids, and semi-solids. A key differentiator for the firm is its specialized expertise in ophthalmic products and sterile manufacturing processes. In 2014, Lusomedicamenta was acquired by Recipharm, a leading global CDMO, which integrated the Portuguese facilities into its international network. The company operates high-standard GMP-compliant facilities located near Lisbon, serving as a strategic hub for European distribution. Its service offerings encompass the entire product lifecycle from initial formulation development to commercial-stage manufacturing and packaging.